With the recent announcement confirming the increased number of PML cases, other information has become available as well. Of the 24 cases, two-thirds have been in Europe and one-third in…
Read More
Fingolimod is an oral agent that is now being researched in three Phase III trials. This is the first of a new class of potential MS medications known as “S1P…